On June 9, 2023, the Securities and Exchange Commission ("SEC") approved new listing standards that were proposed by the New York Stock Exchange ("NYSE") and Nasdaq.

In 2013, relators brought an FCA suit against various lenders and loan servicers.

In recent years, there's been massive uptick in interest in so-called "retail" private equity and predictions are that such growth will continue.

On November 6, 2014, the SEC issued a notice of intention to grant an application for exemptive relief under the Investment Company Act.

When I think about developing a value-based program for pharmaceuticals it's necessary first, I think, to look at what they need practically to do to make that work.

Does the use of a printed manual at the PTAB foreclose later use of the underlying product in litigation?

CAFC Side Steps 314(a) Controversy on Procedural Grounds...

The Federal Trade Commission has announced proposed rule changes that will impact the reportability of pharmaceutical patent licenses under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR Act").

While IPR petitioners may only challenge patent claims based upon patents and printed publications (§§ 102 and 103)...

Earlier this year the Patent Trial & Appeal Board (PTAB) instituted trial in Sling TV, L.L.C. et al. v. Realtime Adaptive Streaming, LLC, IPR2018-01331

There have been a number of developments in the courts, at the USPTO, and on the legislative side over the past few months.

The practical application of an obviousness challenge is simply this: would a person of ordinary skill in the art find the claims to be obvious, in view of the prior art in front of them.

It's important to bear in mind that experts have a different function at the PTAB than they do in district court; they're presented in a different way.

Last month, the Patent Trial & Appeal Board (PTAB) issued an Order explaining that maintaining multiple, concurrent proceedings per patent presents a significant burden for the Board.

While I will discuss my more detailed impressions during tomorrow's webinar, a few quick thoughts.

Over the years, the Patent Trial & Appeal Board had become panel dependent in assessing questions of public accessibility at institution.

Yesterday, the Patent Trial & Appeal Board (PTAB) designated two older AIA trial decisions, and one recent decision

Phillips Claim Construction Rule Imminent

Under Section 337 of the Tariff Act of 1930, the International Trade Commission (ITC) is required to conclude its investigations and make determinations ...

The United States Patent and Trademark Office (USPTO) has issued a Notice of Proposed Rulemaking (NPRM) to allocate the burdens of persuasion on motions to amend in AIA trial proceedings.